Asthma Clinical Trial
Official title:
Asthma Educational Intervention on Physical Education Teachers in Primary Schools
| Verified date | June 2012 |
| Source | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Undertake a study of educational intervention in primary schools in Andalusia
HYPOTHESIS:
There are differences in quality of life associated with asthma (as measured by the
questionnaire PAQLQ) and the level of asthma control in students with asthma aged 11 and 12
years who receive an educational intervention with their peers without asthma versus those
receiving standard information in schools.
OBJECTIVES: To compare the control of asthma symptoms, quality of life in asthma and asthma
knowledge among a group receiving an educational intervention delivered by specialist
teachers of physical education (MEEF) in Primary Schools (CEIP) and control.
MÉTODOS group: Randomized controlled single-blind.
POPULATION: Students of 11 and 12 years old in Andalusia
Sample size: 258 children / children with asthma for a mean contrast (alpha error of 3.4%.
80% power, a confidence level of 95% considering 20% loss. 2580 students will be enrolled
prevalence of asthma 10%) . Conglomerates of the CEIP in urban, rural, public and
private-reached.
INTERVENTION: Training MEEF with the educational program "Sports and Health Asthma and
subsequent delivery, then the students MEEF are 5th and 6th grade ( 3 sessions). CONTROL: The
standard instruction in schools. OUTCOME VARIABLES: Quality of life (Juniper) and "control
del asthma en niños"(CAN) in asthmatics, Knowledge (NAKQ questionnaire) and attitudes toward
asthma (all students and teachers). Pre-intervention (T0), post-intervention at 5-6 months
(T1)
Independent variables: Sex, suffering or not asthma, intervention / control, type CEIP.
STATISTICAL ANALYSIS: Comparison of continuous variables: T Students (If normal distribution)
"Mann-Whitney (If non-normal distribution). To study qualitative variables chi-square test
(normal distribution) and Kruskal-Wallis ( no-normal distribution).
| Status | Unknown status |
| Enrollment | 4506 |
| Est. completion date | July 2013 |
| Est. primary completion date | July 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 10 Years to 13 Years |
| Eligibility |
Inclusion Criteria: - Studying in fifth and sixth year of primary education Exclusion Criteria: - Intellectual deficit to answer questions. - Do not to sign the parent informed consent |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Centro de Salud La Candelaria | Sevilla | Andalucía |
| Spain | Universidad Pablo de Olavide | Sevilla | Andalucía |
| Lead Sponsor | Collaborator |
|---|---|
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Quality of life | We measure the quality of life through the Pediatric Asthma Quality of Life Questionnaire (Elizabeth Juniper) | 6 months | |
| Primary | Asthma Control | 6 months | ||
| Secondary | Measurement of attitudes toward asthma | 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|